The guidelines are part of a national trend by municipal governments and private firms struggling to manage ballooning costs ...
Millions of Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and ...
If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...
The COVID pandemic set in motion trends with alcohol use that have persisted. Disruptions in work, school and lifestyle have ...
Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...
The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...
The Biden administration’s proposal to expand coverage of weight-loss drugs to Medicare and Medicaid recipients is expensive ...
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...